Dr. David M. Pariser
Claim this profileVirginia Clinical Research, Inc.
Studies Psoriasis
Studies Alopecia
9 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials David M. Pariser is currently running
Baricitinib
for Pediatric Hair Loss
This trial is testing baricitinib, a medication that may help treat severe hair loss. It targets children aged 6 to less than 18 years who have significant hair loss. The medication works by reducing the immune system's activity that causes hair loss.
Recruiting1 award Phase 35 criteria
Deucravacitinib
for Psoriasis
The purpose of this study is to measure the safety and effectiveness of deucravatinib in participants with non-pustular palmoplantar psoriasis and genital psoriasis.
Recruiting2 awards Phase 410 criteria
More about David M. Pariser
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments David M. Pariser has experience with
- Lebrikizumab
- Deucravacitinib
- TDM-105795
- Mirikizumab
- Baricitinib
- LY3972406
Breakdown of trials David M. Pariser has run
Atopic Dermatitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David M. Pariser specialize in?
David M. Pariser focuses on Psoriasis and Alopecia. In particular, much of their work with Psoriasis has involved treating patients, or patients who are undergoing treatment.
Is David M. Pariser currently recruiting for clinical trials?
Yes, David M. Pariser is currently recruiting for 3 clinical trials in Norfolk Virginia. If you're interested in participating, you should apply.
Are there any treatments that David M. Pariser has studied deeply?
Yes, David M. Pariser has studied treatments such as Lebrikizumab, Deucravacitinib, TDM-105795.
What is the best way to schedule an appointment with David M. Pariser?
Apply for one of the trials that David M. Pariser is conducting.
What is the office address of David M. Pariser?
The office of David M. Pariser is located at: Virginia Clinical Research, Inc., Norfolk, Virginia 23502 United States. This is the address for their practice at the Virginia Clinical Research, Inc..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.